Multi-center, double-blind, placebo-controlled, randomized, parallel group study to evaluate the effects of different doses of SH T 00127B [asoprisnil] in women with treatment-resistant menorrhagia aged 30 to 55 years after daily oral administration of multiple doses for 35 up to 50 days

Trial Profile

Multi-center, double-blind, placebo-controlled, randomized, parallel group study to evaluate the effects of different doses of SH T 00127B [asoprisnil] in women with treatment-resistant menorrhagia aged 30 to 55 years after daily oral administration of multiple doses for 35 up to 50 days

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Dec 2008

At a glance

  • Drugs Asoprisnil (Primary)
  • Indications Menorrhagia
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 11 Dec 2008 Last checked against ClinicalTrials.gov record.
    • 21 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top